ACCELLACARE LIMITED

Accellacare Limited is a patient-centred clinical research organisation that connects individuals with clinical studies as a viable care option. By delivering trial visits directly to participants at times and places that suit them, the company removes traditional barriers to enrolment and helps boost both recruitment and retention for sponsors.

The firm's service portfolio includes a comprehensive study-matching platform, personalised support throughout the trial journey, and a global network of research sites and affiliates. Accellacare's approach spans medical, rare and orphan disease studies, ensuring that patients with moderate to severe symptoms can explore new therapeutic possibilities while receiving care in a friendly, relaxed environment.

Committed to the highest standards of safety and regulatory compliance, Accellacare also adapts its processes to minimise risk-such as the enhanced protocols introduced during the COVID-19 pandemic-so participants can engage with confidence and contribute to the future of world health.